Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RABGEF1 pseudogene 2 (RABGEF1P2) is classified as a pseudogene located in the human genome and does not produce a functional protein[6]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they may arise from gene duplication or retrotransposition. As a pseudogene, RABGEF1P2 lacks protein-coding ability and is not involved in molecular signaling pathways as an enzyme, receptor, transporter, or transcription factor. There is no evidence that RABGEF1P2 plays a direct role in biological functions, diseases, or serves as a therapeutic or diagnostic target[6]. This pseudogene should not be confused with its functional counterpart RABGEF1 (commonly known as Rabex-5), which is a guanine nucleotide exchange factor involved in endocytosis, autophagy, and several cellular signaling processes[2][3][4][5], but these functions do not apply to the pseudogene RABGEF1P2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RABGEF1 pseudogene 2 (RABGEF1P2).